
GlucoTrack, Inc.
GlucoTrack, Inc. (GCTK) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GCTK · as of Sep 30, 2025
Ownership Breakdown
8
Institutional Holders
▼ 2 vs Q2
$41,504
Total Inst. Value
▲ $1,416 vs Q2
567,456
Shares Outstanding
freeFloat 99.64%
6,298
13F Shares Held
▼ 383 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GCTK largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ALERUS FINANCIAL NA surgical & medical instruments & apparatus | 5.0K | 55.59% | 55.59% | $32.95M | Nov 10, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) surgical & medical instruments & apparatus | 806 | 8.96% | 8.96% | $5.31M | Nov 14, 2025 | ▼ 966 |
MORGAN STANLEY surgical & medical instruments & apparatus | 401 | 4.46% | 4.46% | $2.64M | May 27, 2026 | ▲ 400 |
UBS GROUP AG surgical & medical instruments & apparatus | 40 | 0.44% | 0.44% | $263,000 | Nov 13, 2025 | ▲ 39 |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. surgical & medical instruments & apparatus | 34 | 0.38% | 0.38% | $224,000 | Nov 13, 2025 | — held |
SBI SECURITIES CO., LTD. surgical & medical instruments & apparatus | 9 | 0.10% | 0.10% | $59,000 | Nov 5, 2025 | ▼ 1 |
BANK OF AMERICA CORP /DE/ surgical & medical instruments & apparatus | 7 | 0.08% | 0.08% | $46,000 | Feb 3, 2026 | ▼ 4.1K |
ADVISOR GROUP HOLDINGS, INC. surgical & medical instruments & apparatus | 1 | 0.01% | 0.01% | $7,000 | Nov 14, 2025 | — held |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO surgical & medical instruments & apparatus | 0 | 0.00% | 0.00% | $0 | Nov 14, 2025 | EXIT |
FMR LLC surgical & medical instruments & apparatus | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+439 shares1
New Positions
first time holders3
Decreased
−5.0K shares3
Sold Out
fully exitedNet shares change (top 50)
4.6K
+439 / −5.0K
Net new holders
-3
1 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GCTK insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Balo Andrew K director | Oct 3, 2025 | Award | 1,285 | — | — | 4.7K | Form 4 ↗ |
Balo Andrew K director | Oct 3, 2025 | Award | 4,055 | $7.40 | $30.0K | 4.1K | Form 4 ↗ |
Balo Andrew K director | Jul 11, 2025 | Award | 3,332 | — | — | 3.4K | Form 4 ↗ |
Balo Andrew K director | Mar 25, 2025 | Award | 75 | — | — | 75 | Form 4 ↗ |
Malave Luis director | Oct 3, 2025 | Award | 463 | — | — | 4.1K | Form 4 ↗ |
Malave Luis director | Oct 3, 2025 | Award | 4,055 | $7.40 | $30.0K | 4.1K | Form 4 ↗ |
Malave Luis director | Jul 11, 2025 | Award | 1,200 | — | — | 3.6K | Form 4 ↗ |
Malave Luis director | Mar 25, 2025 | Award | 35 | — | — | 2.4K | Form 4 ↗ |
Carter Erin Catherine director | Oct 3, 2025 | Award | 4,055 | $7.40 | $30.0K | 4.1K | Form 4 ↗ |
Carter Erin Catherine director | Oct 3, 2025 | Award | 386 | — | — | 2.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
GlucoTrack, Inc. (GCTK) is primarily owned by institutional investors, who hold approximately 1.1% of total shares outstanding. Company insiders own approximately 0.36%, while retail and public investors account for the remaining 98.53%.
The largest institutional shareholder of GlucoTrack, Inc. is ALERUS FINANCIAL NA, holding approximately 5,000 shares — equal to 55.59% of outstanding shares — as of September 30, 2025.
A total of 8 institutional investors currently hold GCTK stock, with a combined institutional value of approximately $41,504 as of the most recent 13F filing period.
Frequently asked questions
GCTK ownershipGlucoTrack, Inc. (GCTK) is primarily owned by institutional investors, who hold approximately 1.1% of shares. The largest shareholder is ALERUS FINANCIAL NA with a 55.59% stake. Company insiders hold 0.36%. Data sourced from SEC Form 13F as of September 30, 2025.